MANILA, Philippines — The Department of Health (DOH) and the Food and Drug Administration (FDA) reiterated their position on Monday that they do not recommend using the anti-parasitic drug Ivermectin for COVID-19 care, stating that existing “evidence” does not support such claims.
The agencies cited a study of six trials conducted by the Philippine COVID-19 Clinical Practice Guidelines (CPG) that concluded the drug “did not significantly reduce” the risk of death in patients with moderate to severe cases.
It was not also correlated with any of the other clinically relevant outcomes studied, including clinical progress from Day 6 to Day 10, clinical worsening, or the nee…
Keep on reading: DOH, FDA: Recent trials indicate Ivermectin can’t treat COVID-19